Wedbush Maintains Neutral on M.D.C. Holdings, Raises Price Target to $51
Portfolio Pulse from Benzinga Newsdesk
Wedbush analyst Jay McCanless has maintained a Neutral rating on M.D.C. Holdings (NYSE:MDC) and raised the price target from $28 to $51.

July 31, 2023 | 4:21 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Wedbush analyst has maintained a Neutral rating on M.D.C. Holdings and raised the price target from $28 to $51.
The news directly pertains to M.D.C. Holdings as the analyst from Wedbush has maintained a Neutral rating on the company and raised the price target. This suggests that the analyst sees potential in the company but also some risks, hence the Neutral rating. The increase in price target could lead to increased investor interest, but the impact on the stock price in the short term is uncertain due to the Neutral rating.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100